DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
4.240
+0.120 (2.91%)
Jun 4, 2025, 4:00 PM - Market closed

DiaMedica Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1822321084299190
Upgrade
Market Cap Growth
54.48%115.41%157.97%-57.63%-48.10%226.30%
Upgrade
Enterprise Value
14318252651160
Upgrade
Last Close Price
4.205.432.841.583.7310.14
Upgrade
PB Ratio
5.305.702.111.312.247.30
Upgrade
P/TBV Ratio
5.305.702.111.312.247.30
Upgrade
Debt / Equity Ratio
0.010.010.010.020.000.01
Upgrade
Quick Ratio
7.848.2319.1215.4929.6913.73
Upgrade
Current Ratio
8.028.2819.2715.6129.8213.77
Upgrade
Return on Equity (ROE)
-67.25%-53.27%-46.77%-36.06%-38.81%-73.10%
Upgrade
Return on Assets (ROA)
-41.27%-33.18%-30.02%-21.89%-23.16%-42.73%
Upgrade
Return on Capital (ROIC)
-44.88%-36.05%-31.74%-22.92%-24.30%-46.79%
Upgrade
Earnings Yield
-14.99%-10.53%-17.98%-32.73%-13.78%-6.47%
Upgrade
FCF Yield
-12.55%-9.52%-17.40%-27.74%-12.45%-4.86%
Upgrade
Buyback Yield / Dilution
-17.44%-24.07%-23.16%-27.29%-32.48%-30.80%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q